Psoriasis and Oropharyngeal blistering
Summary:
Oropharyngeal blistering is found among people with Psoriasis, especially for people who are female, 60+ old.
The study analyzes which people have Oropharyngeal blistering with Psoriasis. It is created by eHealthMe based on reports of 26 people who have Psoriasis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Psoriasis?
Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,474 drugs and 1,695 conditions by eHealthMe. Check the latest studies of Psoriasis.
What is Oropharyngeal blistering?
Oropharyngeal blistering (blister of oropharynx) is found to be associated with 255 drugs and 439 conditions by eHealthMe. Check the latest studies of Oropharyngeal blistering.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
26 people who have Psoriasis and Oropharyngeal Blistering are studied.

Gender of people who have Psoriasis and experienced Oropharyngeal Blistering *:
- female: 76.92 %
- male: 23.08 %
Age of people who have Psoriasis and experienced Oropharyngeal Blistering *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 5.26 %
- 30-39: 10.53 %
- 40-49: 21.05 %
- 50-59: 26.32 %
- 60+: 36.84 %
Common co-existing conditions for these people *:
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 23.08%
- High Blood Pressure: 4 people, 15.38%
- Seasonal Allergy (allergic condition due to certain season): 2 people, 7.69%
- Joint Pain: 2 people, 7.69%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 7.69%
- Hypersensitivity: 2 people, 7.69%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 7.69%
- Depression: 2 people, 7.69%
- Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 1 person, 3.85%
- Insomnia (sleeplessness): 1 person, 3.85%
Common drugs taken by these people *:
- Humira: 10 people, 38.46%
- Cosentyx: 9 people, 34.62%
- Enbrel: 3 people, 11.54%
- Methotrexate: 3 people, 11.54%
- Synthroid: 2 people, 7.69%
- Cortisone Acetate: 2 people, 7.69%
- Cytomel: 2 people, 7.69%
- Valium: 2 people, 7.69%
- Zithromax: 1 person, 3.85%
- Levothroid: 1 person, 3.85%
Common symptoms for these people *:
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 6 people, 23.08%
- Oral Mucosal Blistering (mouth ulcer): 6 people, 23.08%
- Oropharyngeal Pain: 5 people, 19.23%
- Joint Pain: 4 people, 15.38%
- Oral Candidiasis (fungal infection of mouth): 4 people, 15.38%
- Rashes (redness): 4 people, 15.38%
- Dyspnea (difficult or laboured breathing): 3 people, 11.54%
- Stomatitis (inflammation of mucous membrane of mouth): 3 people, 11.54%
- Eye Swelling: 3 people, 11.54%
- Oral Herpes (viral infection of mouth): 3 people, 11.54%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Oropharyngeal blistering?
- Check whether Oropharyngeal blistering is associated with a drug or a conditionRelated publications that referenced our studies
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Psoriasis (508,164 reports)
- Oropharyngeal blistering (2,102 reports)
All the drugs that are associated with Oropharyngeal blistering:
- Oropharyngeal blistering (255 drugs)
All the conditions that are associated with Oropharyngeal blistering:
- Oropharyngeal blistering (439 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Oropharyngeal blistering and Psoriasis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Hctz cause Hair Color Changes? - now
- Could Sudafed 12 Hour cause Pancytopenia? - a second ago
- Could Aripiprazole cause Consciousness - Decreased? - a second ago
- Oedema Peripheral and Fainting - 4 seconds ago
- Could Fentanyl-100 cause Bedridden? - 4 seconds ago
- Could Aripiprazole cause Male Orgasmic Disorder? - 7 seconds ago
- Nuclear Magnetic Resonance Imaging Abdominal and Back Pain - 9 seconds ago
- Neck Pain and Insomnia - 11 seconds ago
- Gabapentin and Imodium Multi-Symptom Relief drug interactions for men aged 60+ - 16 seconds ago
- Could Tretinoin cause Heart Palpitations? - 26 seconds ago